CLINICAL_TRIALS
trial_result
· 2019-04-30
Clinical Trial Update: MEmbranous Nephropathy Trial Of Rituximab [Phase 2, Phase 3]
Summary
A phase 2/3 trial evaluating rituximab for idiopathic membranous nephropathy has completed with results available as of 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Idiopathic Membranous Nephropathy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-04-30